Free Trial
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free CCCC Stock Alerts

C4 Therapeutics (CCCC) Institutional Ownership

C4 Therapeutics logo
$2.78 -0.28 (-9.15%)
Closing price 04:00 PM Eastern
Extended Trading
$2.85 +0.07 (+2.37%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for C4 Therapeutics (NASDAQ:CCCC)

Current
Institutional Ownership
Percentage
78.81%
Number of
Institutional Buyers
(last 12 months)
54
Total
Institutional Inflows
(last 12 months)
$54.74M
Number of
Institutional Sellers
(last 12 months)
15
Total
Institutional Outflows
(last 12 months)
$25.68M
Get CCCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling C4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CCCC Institutional Buying and Selling by Quarter

C4 Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/6/2026Congress Asset Management Co.1,256,692$4.19M0.0%+25.2%1.021%
9/9/2026WINTON GROUP Ltd11,100$52K0.0%-55.1%0.009%
9/9/2026Squarepoint Ops LLC170,834$798K0.0%+320.1%0.139%
8/27/2026Corient Private Wealth LP10,007$47K0.0%-53.2%0.008%
8/22/2026Seven Fleet Capital Management LP381,169$1.78M0.3%+567.8%0.310%
8/21/2026AXQ Capital LP10,745$50K0.0%-87.5%0.009%
8/21/2026Velan Capital Investment Management LP570,000$2.66M1.6%N/A0.463%
8/20/2026Headlands Technologies LLC153,972$719K0.1%N/A0.125%
8/19/2026Wellington Management Group LLP227,768$1.06M0.0%N/A0.185%
8/6/2026Bank of New York Mellon Corp249,517$1.17M0.0%N/A0.226%
7/10/2026Wasatch Advisors LP3,522,644$16.45M0.1%+18.9%3.186%
6/4/2026Seven Fleet Capital Management LP57,076$150K0.0%N/A0.052%
5/21/2026CTC Alternative Strategies Ltd.10,792$28K0.1%N/A0.010%
5/19/2026Bank of America Corp DE2,359,241$6.21M0.0%-1.2%2.134%
5/19/2026Stempoint Capital LP453,236$1.19M0.2%N/A0.410%
5/18/2026ADAR1 Capital Management LLC43,000$113K0.0%N/A0.039%
5/18/2026Readystate Asset Management LP49,586$130K0.0%N/A0.045%
5/16/2026SummitTX Capital L.P.10,466$28K0.0%N/A0.009%
5/16/2026Orbimed Advisors LLC856,353$2.25M0.0%-39.0%0.774%
5/15/2026OMERS ADMINISTRATION Corp59,700$157K0.0%-49.3%0.054%
5/14/2026Renaissance Technologies LLC2,461,815$6.48M0.0%+53.6%2.234%
5/14/2026Sei Investments Co.25,134$66K0.0%N/A0.023%
5/7/2026Dimensional Fund Advisors LP442,518$1.16M0.0%+49.3%0.402%
4/21/2026Wasatch Advisors LP2,961,761$7.79M0.1%-31.8%3.035%
2/23/2026Virtu Financial LLC20,655$39K0.0%N/A0.021%
2/19/2026Invesco Ltd.268,350$513K0.0%+39.9%0.277%
2/18/2026XTX Topco Ltd104,458$200K0.0%-30.3%0.108%
2/18/2026Quadrature Capital Ltd133,112$254K0.0%N/A0.137%
2/18/2026Orbimed Advisors LLC1,404,902$2.68M0.1%-73.2%1.450%
2/18/2026Millennium Management LLC1,188,969$2.27M0.0%-41.3%1.227%
2/18/2026Man Group plc156,098$298K0.0%+72.9%0.161%
2/18/2026Intrepid Family Office LLC55,000$105K0.1%-21.4%0.057%
2/18/2026Engineers Gate Manager LP24,416$47K0.0%+49.9%0.025%
2/18/2026Bridgeway Capital Management LLC131,100$250K0.0%+64.1%0.135%
2/18/2026683 Capital Management LLC400,000$764K0.0%N/A0.413%
2/17/2026RA Capital Management L.P.8,000,000$15.28M0.2%N/A8.255%
2/17/2026Bain Capital Life Sciences Investors LLC7,171,910$13.70M1.0%+545.0%7.401%
2/17/2026Atom Investors LP104,964$200K0.0%N/A0.108%
2/17/2026ExodusPoint Capital Management LP62,165$119K0.0%N/A0.064%
2/17/2026Graham Capital Management L.P.102,198$195K0.0%+151.5%0.105%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
2/16/2026Squarepoint Ops LLC136,054$260K0.0%+1,247.2%0.140%
2/16/2026OMERS ADMINISTRATION Corp117,700$225K0.0%N/A0.121%
2/16/2026Barclays PLC219,204$419K0.0%+409.0%0.226%
2/13/2026Marshall Wace LLP265,027$506K0.0%+149.4%0.273%
2/13/2026Hudson Bay Capital Management LP111,551$213K0.0%N/A0.115%
2/13/2026Charles Schwab Investment Management Inc.449,432$858K0.0%+28.2%0.464%
2/13/2026State Street Corp342,773$655K0.0%+19.3%0.354%
2/13/2026Wells Fargo & Company MN809,260$1.55M0.0%+4,236.9%0.835%
2/12/2026Wasatch Advisors LP4,344,918$8.30M0.0%-10.5%4.483%
2/12/2026Jane Street Group LLC874,794$1.67M0.0%+329.7%0.903%
2/12/2026Renaissance Technologies LLC1,602,580$3.06M0.0%+71.0%1.654%
2/12/2026Dimensional Fund Advisors LP296,480$566K0.0%-15.1%0.306%
2/11/2026LPL Financial LLC243,305$465K0.0%+21.1%0.251%
2/10/2026Goldman Sachs Group Inc.1,089,020$2.08M0.0%+136.8%1.124%
2/9/2026Geode Capital Management LLC988,878$1.89M0.0%+36.3%1.020%
1/30/2026Delta Investment Management LLC20,000$38K0.0%N/A0.021%
1/14/2026Hennion & Walsh Asset Management Inc.237,137$453K0.0%+15.7%0.245%
11/19/2025Caitong International Asset Management Co. Ltd19,146$43K0.0%N/A0.020%
11/17/2025Jacobs Levy Equity Management Inc.503,145$1.12M0.0%+13.9%0.519%
11/17/2025Voleon Capital Management LP28,420$63K0.0%N/A0.029%
11/17/2025Wasatch Advisors LP4,852,741$10.77M0.1%-34.6%5.007%
11/17/2025Qube Research & Technologies Ltd115,973$257K0.0%N/A0.120%
11/17/2025Mariner LLC128,237$285K0.0%-3.4%0.132%
11/17/2025Bank of America Corp DE2,053,162$4.56M0.0%+2.2%2.119%
11/17/2025Algert Global LLC106,300$236K0.0%N/A0.110%
11/14/2025Zacks Investment Management13,043$29K0.0%N/A0.018%
11/14/2025Man Group plc90,278$200K0.0%+15.0%0.127%
11/14/2025Orbimed Advisors LLC5,235,146$11.62M0.3%-23.4%7.356%
11/14/2025Shay Capital LLC420,000$932K0.1%N/A0.590%
11/14/2025Two Sigma Investments LP834,726$1.85M0.0%+22.1%1.173%
11/14/2025Bridgeway Capital Management LLC79,900$177K0.0%-23.8%0.112%
11/13/2025BNP Paribas Financial Markets80,806$179K0.0%-60.8%0.114%
11/13/2025Jefferies Financial Group Inc.38,200$85K0.0%N/A0.054%
11/12/2025Dimensional Fund Advisors LP349,289$775K0.0%-19.1%0.491%
11/12/2025R Squared Ltd17,880$40K0.0%-41.5%0.025%
11/7/2025Crestwood Advisors Group LLC66,536$148K0.0%+129.4%0.093%
11/7/2025Vanguard Group Inc.3,191,557$7.09M0.0%+5.7%4.484%
11/4/2025State of Wyoming82,509$183K0.0%N/A0.116%
8/15/2025Tower Research Capital LLC TRC 40,592$58K0.0%+458.0%0.057%
8/15/2025Wasatch Advisors LP7,424,662$10.62M0.1%+10.4%10.432%
8/15/2025Man Group plc78,487$112K0.0%-8.3%0.110%
8/15/2025BNP Paribas Financial Markets206,177$295K0.0%+1,039.4%0.290%
8/15/2025Bridgeway Capital Management LLC104,900$150K0.0%-19.2%0.147%
8/15/2025Bank of America Corp DE2,008,004$2.87M0.0%+0.9%2.821%
8/15/2025Adage Capital Partners GP L.L.C.200,000$286K0.0%-87.1%0.281%
8/14/2025Jane Street Group LLC492,612$704K0.0%+3,816.8%0.692%
8/13/2025Invesco Ltd.155,017$222K0.0%+11.1%0.218%
8/12/2025XTX Topco Ltd108,278$155K0.0%+170.0%0.152%
8/12/2025Dynamic Technology Lab Private Ltd21,476$31K0.0%N/A0.030%
8/12/2025Catalyst Funds Management Pty Ltd28,300$40K0.0%N/A0.040%
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
8/8/2025Geode Capital Management LLC745,053$1.07M0.0%-47.9%1.049%
8/6/2025Savant Capital LLC26,347$38K0.0%N/A0.037%
8/5/2025Crestwood Advisors Group LLC29,000$41K0.0%N/A0.041%
8/1/2025Y Intercept Hong Kong Ltd52,521$75K0.0%N/A0.074%
7/31/2025R Squared Ltd30,587$44K0.0%N/A0.043%
7/30/2025Brookstone Capital Management29,325$42K0.0%N/A0.041%
6/27/2025Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
5/29/2025Rhumbline Advisers89,633$143K0.0%-10.4%0.126%
5/21/2025Acadian Asset Management LLC27,675$43K0.0%N/A0.039%
5/16/2025Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%


CCCC Institutional Ownership - Frequently Asked Questions

During the previous two years, 117 institutional investors and hedge funds held shares of C4 Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($25.12M), Lynx1 Capital Management LP ($24.67M), Wasatch Advisors LP ($16.45M), RA Capital Management L.P. ($15.28M), Bain Capital Life Sciences Investors LLC ($13.70M), Vanguard Group Inc. ($7.09M), and Point72 Asset Management L.P. ($6.85M).Learn more on C4 Therapeutics' institutional investors.

78.81% of C4 Therapeutics' stock is owned by institutional investors. Learn more on CCCC's institutional investor holdings.

Of the 100 institutional investors that purchased C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($8M), Bain Capital Life Sciences Investors LLC ($6.06M), Wasatch Advisors LP ($2.49M), Renaissance Technologies LLC ($1.52M), Jane Street Group LLC ($1.20M), Adage Capital Partners GP L.L.C. ($1.03M), and Point72 Asset Management L.P. ($923.27K).

Institutional investors have bought a total of 24,431,477 shares in the last 24 months. This purchase volume represents approximately $54.74M in transactions.

Of the 15 institutional investors that sold C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($5.97M), Wasatch Advisors LP ($4.46M), Millennium Management LLC ($835.26K), Dimensional Fund Advisors LP ($135.41K), BNP Paribas Financial Markets ($125.37K), AXQ Capital LP ($75.53K), and OMERS ADMINISTRATION Corp ($58K).

Institutional investors have sold a total of 11,822,480 shares in the last 24 months. This volume of shares sold represents approximately $25.68M in transactions.


Related Companies

Institutional ownership data for NASDAQ:CCCC is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 10/6/2026. New 13F filings are added each quarter as they're published.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel